![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 39579 |
FusionGeneSummary for TRIO_CTNNA2 |
![]() |
Fusion gene information | Fusion gene name: TRIO_CTNNA2 | Fusion gene ID: 39579 | Hgene | Tgene | Gene symbol | TRIO | CTNNA2 | Gene ID | 7204 | 1496 |
Gene name | trio Rho guanine nucleotide exchange factor | catenin alpha 2 | |
Synonyms | ARHGEF23|MEBAS|MRD44|tgat | CAP-R|CAPR|CT114|CTNR | |
Cytomap | 5p15.2 | 2p12 | |
Type of gene | protein-coding | protein-coding | |
Description | triple functional domain proteinPTPRF-interacting proteintriple functional domain (PTPRF interacting) | catenin alpha-2alpha-N-cateninalpha-catenin-related proteincadherin-associated protein, relatedcancer/testis antigen 114catenin (cadherin-associated protein), alpha 2 | |
Modification date | 20180527 | 20180522 | |
UniProtAcc | O75962 | P26232 | |
Ensembl transtripts involved in fusion gene | ENST00000344204, ENST00000537187, ENST00000509967, ENST00000515710, ENST00000344135, | ENST00000466387, ENST00000496558, ENST00000361291, ENST00000402739, ENST00000540488, ENST00000541047, ENST00000343114, ENST00000496251, ENST00000409266, | |
Fusion gene scores | * DoF score | 26 X 18 X 10=4680 | 15 X 12 X 9=1620 |
# samples | 27 | 15 | |
** MAII score | log2(27/4680*10)=-4.11547721741994 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/1620*10)=-3.43295940727611 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TRIO [Title/Abstract] AND CTNNA2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | SARC | TCGA-DX-A8BM-01A | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000344204 | ENST00000466387 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000344204 | ENST00000496558 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000344204 | ENST00000361291 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000344204 | ENST00000402739 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000344204 | ENST00000540488 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000344204 | ENST00000541047 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000344204 | ENST00000343114 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000344204 | ENST00000496251 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000344204 | ENST00000409266 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000466387 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000496558 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000361291 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000402739 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000540488 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000541047 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000343114 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000496251 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000537187 | ENST00000409266 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000466387 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000496558 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000361291 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000402739 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000540488 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000541047 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000343114 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000496251 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
5CDS-intron | ENST00000509967 | ENST00000409266 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000466387 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000496558 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000361291 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000402739 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000540488 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000541047 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000343114 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000496251 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000515710 | ENST00000409266 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000466387 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000496558 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000361291 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000402739 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000540488 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000541047 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000343114 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000496251 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
intron-intron | ENST00000344135 | ENST00000409266 | TRIO | chr5 | 14336836 | + | CTNNA2 | chr2 | 79520313 | + |
Top |
FusionProtFeatures for TRIO_CTNNA2 |
![]() |
Hgene | Tgene |
TRIO | CTNNA2 |
Guanine nucleotide exchange factor (GEF) for RHOA andRAC1 GTPases (PubMed:8643598, PubMed:27418539). Involved incoordinating actin remodeling, which is necessary for cellmigration and growth (PubMed:10341202). In developing hippocampalneurons, limits dendrite formation, without affecting theestablishment of axon polarity. Once dendrites are formed,involved in the control of synaptic function by regulating theendocytosis of AMPA-selective glutamate receptors (AMPARs) at CA1excitatory synapses (By similarity). May act as a regulator ofadipogenesis (By similarity). {ECO:0000250|UniProtKB:F1M0Z1,ECO:0000269|PubMed:10341202, ECO:0000269|PubMed:27418539,ECO:0000269|PubMed:8643598}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TRIO_CTNNA2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TRIO_CTNNA2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
TRIO | FLNA, BLMH, RAC1, PTPRF, RHOA, CDC5L, DISC1, EXOC1, ITSN2, BCAS2, DAB2, NAV1, NAV2, NAV3, RHOG, MAPRE1, NTRK1, CFAP45, PPM1F, RPE, SSU72, CENPJ, MYC, ZSCAN26, PTPRD, PTPRS, ZNF232, ZNF785, TRIM25 | CTNNA2 | PAN2, PPP2R1A, FBXW11, CD27, UTP3, SAPCD1, CTNNB1, JUP, NTRK1, SDHAF2, GAN, MCM2, EGFR, CDH1, CDH8, CDH5, CTNNBIP1, DUSP22, FBXL5, CIR1, G3BP1, UBE2A, TES |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TRIO_CTNNA2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TRIO_CTNNA2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | TRIO | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
Hgene | TRIO | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | TRIO | C0032927 | Precancerous Conditions | 1 | CTD_human |
Tgene | CTNNA2 | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
Tgene | CTNNA2 | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | CTNNA2 | C0038356 | Stomach Neoplasms | 1 | CTD_human |